0.1185
5.50%
-0.0069
Dopo l'orario di chiusura:
.12
0.0015
+1.27%
Conduit Pharmaceuticals Inc Borsa (CDT) Ultime notizie
In the Green: Conduit Pharmaceuticals Inc (CDT) Closes at 0.13, Up/Down -2.64 from Previous Day - The Dwinnex
CDT Stock Sees Decline of Approximately -3.66% in Last Five Days - Knox Daily
Conduit Pharmaceuticals Inc (CDT) expanding its growth trajectory ahead - SETE News
Conduit Pharmaceuticals Inc [CDT] Insider Activity: An Update for Investors - Knox Daily
Metric Analysis: Conduit Pharmaceuticals Inc (CDT)’s Key Ratios in the Limelight - The Dwinnex
Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Director Andrew Regan Sells 1,514,100 Shares - Defense World
Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Director Andrew Regan Sells 150,000 Shares of Stock - Defense World
CDT Shares Experience Decline in Value - Knox Daily
Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Director Andrew Regan Sells 35,923 Shares - Defense World
Mercer Global Advisors Inc. ADV Reduces Stock Position in Dimensional Emerging Markets Core Equity 2 ETF (NYSEARCA:DFEM) - Defense World
Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Director Andrew Regan Sells 1,005,200 Shares - Defense World
Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Director Andrew Regan Sells 1,389,820 Shares - Defense World
Conduit Pharmaceuticals executive sells over $4.5 million in stock By Investing.com - Investing.com Canada
Conduit Pharmaceuticals executive sells over $4.5 million in stock - Investing.com
Conduit Pharmaceuticals executive sells over $4.5 million in stock By Investing.com - Investing.com UK
Are Smart Investors Making the Right Decision? Conduit Pharmaceuticals Inc (CDT) - SETE News
Akoustis Technologies Inc: How Does AKTS Perform? - Stocks Register
CDT’s Stock Market Adventure: -96.92% YTD Growth Amidst Volatility - The InvestChronicle
Was Conduit Pharmaceuticals Inc (CDT)’s session last reading good? - US Post News
Insider’s View: Deciphering Conduit Pharmaceuticals Inc (CDT)’s Financial Health Through Ratios - The Dwinnex
Conduit Pharmaceuticals Inc [CDT] Revenue clocked in at $0.00 million, down -96.87% YTD: What’s Next? - The DBT News
Conduit Pharmaceuticals Inc (CDT) Stock: A Year of Highs and Lows - The InvestChronicle
Stocks of Conduit Pharmaceuticals Inc (CDT) are poised to climb above their peers - SETE News
Is Conduit Pharmaceuticals Inc (CDT) worth investing in despite its undervalued state? - US Post News
Conduit Pharmaceuticals Inc (CDT)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
Conduit Pharmaceuticals reschedules annual meeting to December - Investing.com
Conduit Pharmaceuticals reschedules annual meeting to December By Investing.com - Investing.com UK
Healthy Upside Potential: Conduit Pharmaceuticals Inc (CDT) - SETE News
Post-Trade Analysis: Conduit Pharmaceuticals Inc (CDT) Slides -5.38, Closing at 0.12 - The Dwinnex
CDT’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Why Zhibao Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket - Benzinga
Market news - Research the market
Vela Technologies reports big drop in asset value - ShareCast
Vela Technologies Reports Mixed Quarterly Results - TipRanks
Short Interest in Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Rises By 386.4% - Defense World
CDT’s Stock Dilemma: Conduit Pharmaceuticals Inc’s Market Performance and Outlook - The InvestChronicle
Conduit Pharmaceuticals Inc (CDT) is looking forward to a strong quarter - SETE News
Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Conduit Pharmaceuticals Inc’s Market Journey: Closing Weak at 0.16, Down -1.64 - The Dwinnex
Conduit Pharmaceuticals Inc (CDT)’s stock chart: A technical perspective - US Post News
AI, Biotech Companies at Risk in Nasdaq's Penny Stock Crackdown - Bloomberg Law
Taking on analysts’ expectations and winning: Conduit Pharmaceuticals Inc (CDT) - SETE News
CDT Stock Earnings: Conduit Pharmaceuticals Reported Results for Q2 2024 - MSN
Conduit Pharmaceuticals Inc Inc. (CDT) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle
Ratio Review: Analyzing Conduit Pharmaceuticals Inc (CDT)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Conduit Pharmaceuticals Inc (CDT) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News
Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Short Interest Down 11.4% in July - Defense World
CrossFirst Bankshares, Inc. (NASDAQ:CFB) Short Interest Update - Defense World
Conduit Pharmaceuticals faces Nasdaq delisting over market value - Investing.com India
Conduit Pharmaceuticals faces Nasdaq delisting over market value - Investing.com
Conduit Pharmaceuticals faces Nasdaq delisting over market value By Investing.com - Investing.com UK
Conduit Pharmaceuticals Inc (CDT) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle
Presidio Property Trust, Inc. Announces Earnings for the Second Quarter Ended June 30, 2024 - StockTitan
Conduit to move AZD1656 into clinical trials for AAV, lupus - ANCA Vasculitis News
Why Is Conduit Pharmaceuticals (CDT) Stock Up 12% Today? - InvestorPlace
A significant driver of top-line growth: Conduit Pharmaceuticals Inc (CDT) - SETE News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday - InvestorPlace
Murphy Canyon stock hits 52-week low at $0.16 amid steep decline - Investing.com
Why Serve Robotics Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Market cap of Conduit Pharmaceuticals Inc [CDT] reaches 12.55M – now what? - The DBT News
CDT Stock Earnings: Conduit Pharmaceuticals Reported Results for Q2 2024 - InvestorPlace
Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Sees Large Growth in Short Interest - Defense World
Sonoma Pharmaceuticals Inc. Inc. (SNOA) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
How should investors view Symbotic Inc (SYM)? - US Post News
It would be worthwhile to take a closer look at Ocean Power Technologies (OPTT) - US Post News
The Conduit Pharmaceuticals Inc (CDT) had a good session last reading, didn’t it? - US Post News
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):